HRT Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-90,915
| Closed | -$3.09M | – | 2447 |
|
|
2025
Q1 | $3.09M | Buy |
90,915
+82,277
| +953% | +$2.8M | 0.02% | 518 |
|
|
2024
Q4 | $339K | Buy |
+8,638
| New | +$339K | ﹤0.01% | 1456 |
|
|
2024
Q2 | – | Sell |
-69,429
| Closed | -$4.73M | – | 2177 |
|
|
2024
Q1 | $4.73M | Buy |
+69,429
| New | +$4.73M | 0.03% | 268 |
|
|
2023
Q3 | – | Sell |
-14,093
| Closed | -$791K | – | 2267 |
|
|
2023
Q2 | $791K | Sell |
14,093
-21,391
| -60% | -$1.2M | 0.01% | 1008 |
|
|
2023
Q1 | $1.6M | Buy |
35,484
+21,400
| +152% | +$967K | 0.02% | 678 |
|
|
2022
Q4 | $572K | Buy |
+14,084
| New | +$572K | 0.01% | 1224 |
|
|
2021
Q3 | – | Sell |
-101,731
| Closed | -$16.5M | – | 3082 |
|
|
2021
Q2 | $16.5M | Buy |
101,731
+91,222
| +868% | +$14.8M | 0.15% | 109 |
|
|
2021
Q1 | $1.28M | Buy |
+10,509
| New | +$1.28M | 0.01% | 788 |
|
|
2020
Q3 | – | Sell |
-3,766
| Closed | -$276K | – | 1867 |
|
|
2020
Q2 | $276K | Buy |
+3,766
| New | +$276K | 0.01% | 907 |
|
|
2019
Q1 | – | Sell |
-10,381
| Closed | -$296K | – | 533 |
|
|
2018
Q4 | $296K | Buy |
+10,381
| New | +$296K | 0.04% | 344 |
|